MAO-B-IN-49
MAO-B-IN-49 is a selective and reversible MAO-B inhibitor (IC50 of 1 nM for human MAO-B). MAO-B-IN-49 shows much higher selectivity for MAO-B than for MAO-A (IC50 = 633.9 μM). MAO-B-IN-49 can reduce ROS production induced by Lipopolysaccharides (HY-D1056) (LPS) in HT22 cells. MAO-B-IN-49 demonstrates substantial neuroprotective properties and significantly improves motor dysfunction in MPTP (HY-W114750)-induced mouse models of Parkinson’s disease (PD). MAO-B-IN-49 can be used for the study of PD.
For research use only. We do not sell to patients.
- CAS No.: 3098883-91-8
- Formula: C19H20F2N2O3
- Molecular Weight:362.37
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
hMAO-B 1 nM (IC50) |
hMAO-A 633.9 μM (IC50) |
In Vitro
MAO-B-IN-49 (Compound ZM24) (2-50 μM, 24 h) demonstrates cell viability exceeding 75 % across all tested conditions in HT22 cells[1].
MAO-B-IN-49 (5-20 μM, 24 h) is co-incubated with cells at different concentrations, and Lipopolysaccharides (HY-D1056) (LPS)-induced ROS production is significantly reduced in HT22 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HT22 hippocampal neuronal cell line
-
Concentration:2 μM, 5 μM, 10 μM, 20μM, 50 μM
-
Incubation Time:24 h
-
Result:Demonstrates cell viability exceeding 75 % across all tested conditions.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A Parkinson's disease model was induced in male C57BL/6J mice (2 months old, weighing 20±2 g) by injection of the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)[1].
-
Dosage:10 mg/kg, 30 mg/kg
-
Administration:I.p., 30 mins before MPTP, once daily for 7 days
-
Result:Led to a near-normal restoration of movement patterns, indicating a significant improvement in motor function.
Significantly improved the movement disorder in mice.
Effectively relieved forelimb muscle weakness in mice.
Chemical Information
-
CAS No. 3098883-91-8
-
Molecular Weight 362.37
-
Formula C19H20F2N2O3
-
SMILES
C[C@H](N1CCOC2=C(C1)C=CC(OCC3=CC(F)=C(C=C3)F)=C2)C(N)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)